SEC Form 4 · accession 0001179110-15-011898
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Thomas
Director
Period of report
Aug 6, 2015
Accepted (ET)
Aug 7, 2015 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par value | Aug 6, 2015 | M | 7,500 | $7.92 | A | 28,313 | D | |
| Common Stock, $.01 par valueF4 | Aug 6, 2015 | S | 5,900 | $93.6012 | D | 22,413 | D | |
| Common Stock, $.01 par valueF5 | Aug 6, 2015 | S | 1,600 | $94.2198 | D | 20,813 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1,F2 | $7.92 | Aug 6, 2015 | M | 7,500 | D | Jan 29, 2011 | Jan 29, 2020 | Common Stock | 0 | 7,500 | D |
| Option (right to buy)F1,F3 | $18.94 | holding | — | — | — | Jan 29, 2014 | May 26, 2020 | Common Stock | 0 | 10,000 | D |
Explanation of responses
- F1Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F2These options become exerciseable in annual increments: 1/3 on each of January 29, 2011, January 29, 2012 and January 29, 2013.
- F3These options become exerciseable as following: 50% on the date shown in Table II, Column 6, and 50% on January 29, 2015.
- F4This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $93.0000 and $93.9800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F5This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $94.0100 and $94.4200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.